Detalhe da pesquisa
1.
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.
Gynecol Oncol
; 184: 24-30, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277918
2.
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
J Transl Med
; 21(1): 725, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845764
3.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355448
4.
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
Int J Gynecol Cancer
; 31(9): 1242-1247, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035080
5.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029508
6.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol
; 153(3): 535-540, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979589
7.
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Lancet Oncol
; 17(8): 1137-1146, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402147
8.
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?
Gynecol Oncol
; 136(2): 230-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527364
9.
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
Oncology
; 86(5-6): 351-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942520
10.
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.
BMC Cancer
; 14: 947, 2014 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25495785
11.
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.
J Gynecol Oncol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497108
12.
Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
Gynecol Oncol
; 130(1): 38-42, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623833
13.
Breast/ovarian cancer genetic counseling: Do anxiety, depression, and health care-related fears influence cancer worry and risk perception?
Cancer Med
; 12(18): 19215-19224, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706348
14.
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
Front Oncol
; 13: 1232476, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609387
15.
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Tumori
; 109(5): 490-495, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609207
16.
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1247291, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781174
17.
Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.
Front Oncol
; 13: 1357793, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318323
18.
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
Front Oncol
; 12: 979519, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212444
19.
The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream study.
Front Oncol
; 12: 960387, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36249001
20.
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey.
Front Oncol
; 12: 880008, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35692798